Cor Vasa 2020, 62(5):501-505 | DOI: 10.33678/cor.2019.072

(Ventricular tachycardia as the first manifestation of cardiac sarcoidosis)

Yassin Nagib Yassina, Tomáš Roubíčeka, Jakub Lípab, Rostislav Polášeka
a Kardiocentrum, Krajská nemocnice Liberec, a.s., Liberec
b Radiodiagnostické oddělení, Krajská nemocnice Liberec, a.s., Liberec

Sarcoidosis is a multiorgan granulomatous disease of unknown etiology. Cardiac sarcoidosis is clinically manifested in about 5% of patients with systemic sarcoidosis, but autopsy findings and modern imaging methods indicate significantly higher incidence of asymptomatic cardiac involvement (20-25%). Cardiac involvement is a sign of a worse prognosis and can be life-threatening. Cardiac sarcoidosis has 3 major manifestations - atrioventricular conduction disorders, ventricular arrhythmias, and heart failure. Diagnosis of cardiac sarcoidosis is difficult, especially in the scenario of minimal extracardiac involvement. We present a case of a 63-year-old female without serious comorbidities, who had a sustained ventricular tachycardia as the initial manifestation of predominate cardiac sarcoidosis. Our case emphasizes that although predominate cardiac sarcoidosis is a relatively rare disease, it should be included in the differential diagnosis of ventricular arrhythmia.

Keywords: Cardiac involvement, Sarcoidosis, Ventricular tachycardia,

Received: October 28, 2019; Revised: October 28, 2019; Accepted: November 6, 2019; Published: November 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nagib Yassin Y, Roubíček T, Lípa J, Polášek R. (Ventricular tachycardia as the first manifestation of cardiac sarcoidosis). Cor Vasa. 2020;62(5):501-505. doi: 10.33678/cor.2019.072.
Download citation

References

  1. Birnie DH, Nery PB, Ha AC, et al. Cardiac sarcoidosis. J Am Coll Cardiol 2016;68:411-421. Go to original source... Go to PubMed...
  2. McGrath DS, Goh N, Foley PJ, et al. Sarcoidosis: genes and microbes - soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 2001;18:149-164.
  3. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999;14:735-737. Go to original source... Go to PubMed...
  4. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305-1323. Go to original source... Go to PubMed...
  5. Benjamin AR, Marcie M, John P, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-241. Go to original source... Go to PubMed...
  6. Sawahata M, Sugiyama Y, Nakamura Y, et al. Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan. Respir Med 2015;109:272-278. Go to original source... Go to PubMed...
  7. Byg KE, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994: a registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:46-52.
  8. Iwai K, Tachibana T, Takemura T, et al. Pathological studies on sarcoidosis autopsy, I: epidemiological features of 320 cases in Japan. Acta Pathol Jpn 1993;43:372-376. Go to original source... Go to PubMed...
  9. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995;119:167-172
  10. Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation 2015;131:624-632. Go to original source... Go to PubMed...
  11. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999;138:299-302. Go to original source... Go to PubMed...
  12. Uusimaa P, Ylitalo K, Anttonen O, et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace 2008;10:760-766. Go to original source... Go to PubMed...
  13. Sekhri V, Sanal S, Delorenzo LJ. Cardiac sarcoidosis: a comprehensive review. Arch Med Sci 2011;7:546-554. Go to original source... Go to PubMed...
  14. Lewin RF, Mor R, Spitzer S, et al. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 1985;110:116-122. Go to original source... Go to PubMed...
  15. Lynch JP, Hwang J, Bradfield J, et al. Cardiac involvement in sarcoidosis: Evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med 2014; 35:372-390. Go to original source... Go to PubMed...
  16. Lam CSP, Tolep KA, Metke MP, et al. Coronary sarcoidosis presenting as acute coronary syndrome. Clin Cardiol 2009;32:68-71. Go to original source... Go to PubMed...
  17. Kopřiva P, Gřiva M, Tüdös Z. Srdeční sarkoidóza - praktický průvodce. Cor Vasa 2018;60:155-164. Go to original source...
  18. Hiraga H, Yuwai K, Hiroe M, et al. Guideline for Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases From the Japanese Ministry of Health and Welfare. Tokyo: Japanese Ministry of Health and Welfare, 1993;23-24.
  19. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disorders 2007;27:89-102.
  20. Judson MA. Costabel U, Drent M, et al. The WASOG Sarcoidosis Organ Assessment Instrument Investigators. The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diff Lung Dis 2014;31:19-27
  21. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009;120:1969-1977. Go to original source... Go to PubMed...
  22. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. Am J Roentgenol 2005;185:110-115. Go to original source... Go to PubMed...
  23. E. Hulten, S. Aslam, M. Osborne, et al., Cardiac sarcoidosis - state of the art review, Cardiovasc Diagn Ther 2016;6:50-63.
  24. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest 2005;128:30-35. Go to original source... Go to PubMed...
  25. Lower EE, Baughman RP, et al. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 1990;299:1537. Go to original source... Go to PubMed...
  26. Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000;17:60-66.
  27. Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:70-74.
  28. Barnabe C, McMeekin J, Howarth A, Martin L. Successful treatment of cardiac sarcoidosis with infliximab. J Rheumatol 2008;35:1686-1687. Go to PubMed...
  29. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 2018;15:278-281.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.